In a world where one microscopic mutation can ripple into global disruption, the real heroes are often the ones working ...
Our program provides superior clinical immunology and rheumatology training in a collaborative environment. We have specialty clinics across our medical campus, which is anchored by our 1,200 bed ...
Mechanisms of Allergen-specific Immunotherapy Regulatory T cells may play a key role in the re-induction of allergen tolerance. This review summarizes the current view on immunological mechanisms ...
Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
Please provide your email address to receive an email when new articles are posted on . The need for allergists and immunologists is growing as the number of fellowship applications is falling. 59% of ...
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics ...
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked AI ...
Please provide your email address to receive an email when new articles are posted on . The consensus aims to rectify discrepancies between prior statements. The report was drafted to be understood by ...
Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...
Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focus; In future, Evaxion’s proprietary AI-Immunology™ platform will enable the discovery ...
We have one postdoctoral fellowship position available immediately in the UAB Clinical Immunology and Rheumatology T32 Program (John D. Mountz, PD/PI), funded by the NIH/NIAMS institutional training ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results